An economic valuation of a biotechnology R&D project in a developing economy

Background: Biotechnology complements technological developments in main sectors of economies, such as health, energy, and agriculture, and thus contributes to economic development. It provides solutions to the problems that are frequently faced in developing economies, such as resource constraints,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Erbas,Bahar Celikkol, Memis,Selin Arslanhan
Lenguaje:	English
Publicado:	Pontificia Universidad Católica de Valparaíso 2012
Materias:	biotechnology sector developing economies real options R&D project valuation Turkey
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582012000300001
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0717-34582012000300001
record_format	dspace
spelling	oai:scielo:S0717-345820120003000012012-06-06An economic valuation of a biotechnology R&D project in a developing economyErbas,Bahar CelikkolMemis,Selin Arslanhan biotechnology sector developing economies real options R&D project valuation Turkey Background: Biotechnology complements technological developments in main sectors of economies, such as health, energy, and agriculture, and thus contributes to economic development. It provides solutions to the problems that are frequently faced in developing economies, such as resource constraints, lower productivity and environmental concerns. In order to benefit from biotechnology, its associated markets need to develop and function well to support the developments and transactions of intangible assets, such as technology transfers, license agreements and research and development joint ventures. Economic valuation of the intangible assets is necessary for the development and functioning of these markets. It provides better understanding of value creation at micro scales and its economic and financial dynamics. The literature lacks valuation studies in biotechnology sectors in developing economies. This study performs economic valuation analysis of a research and development project of a Turkish biotechnology company operating in health sector. Turkey, as a developing economy, has slow progress in biotechnology despite its wealth of biological resources and genetic variety. Thus, the study provides an excellent case to analyze valuation issues in developing economies. It uses data from in-depth interviews from the company and employs real options and discounted cash flow (DCF) methods. Results: Developing countries and biotechnology sector introduce additional risks that need to be accounted for in valuation. These risks reduce the value of the project under real options and discounted cash flow methods. Since real options method permits the valuation of options that might arise during the R&D process and provides flexibility to managers to act, it results in higher values compared to discounted cash flow method. The grant from a public institution that partially financed the Project reduces the discount factor and thus increases the value of it. Conclusions: Economic values of biotechnology intangibles in developing countries are affected by country and sector risks and public financing. Thus, both microeconomic and macroeconomic policy interventions are important for the development of biotechnology in these economies. While public financing enables the risky R&D projects to take place, it makes them more valuable than they would be under no intervention. Long run effects of these interventions require diligent analyses.info:eu-repo/semantics/openAccessPontificia Universidad Católica de ValparaísoElectronic Journal of Biotechnology v.15 n.3 20122012-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582012000300001en
institution	Scielo Chile
collection	Scielo Chile
language	English
topic	biotechnology sector developing economies real options R&D project valuation Turkey
spellingShingle	biotechnology sector developing economies real options R&D project valuation Turkey Erbas,Bahar Celikkol Memis,Selin Arslanhan An economic valuation of a biotechnology R&D project in a developing economy
description	Background: Biotechnology complements technological developments in main sectors of economies, such as health, energy, and agriculture, and thus contributes to economic development. It provides solutions to the problems that are frequently faced in developing economies, such as resource constraints, lower productivity and environmental concerns. In order to benefit from biotechnology, its associated markets need to develop and function well to support the developments and transactions of intangible assets, such as technology transfers, license agreements and research and development joint ventures. Economic valuation of the intangible assets is necessary for the development and functioning of these markets. It provides better understanding of value creation at micro scales and its economic and financial dynamics. The literature lacks valuation studies in biotechnology sectors in developing economies. This study performs economic valuation analysis of a research and development project of a Turkish biotechnology company operating in health sector. Turkey, as a developing economy, has slow progress in biotechnology despite its wealth of biological resources and genetic variety. Thus, the study provides an excellent case to analyze valuation issues in developing economies. It uses data from in-depth interviews from the company and employs real options and discounted cash flow (DCF) methods. Results: Developing countries and biotechnology sector introduce additional risks that need to be accounted for in valuation. These risks reduce the value of the project under real options and discounted cash flow methods. Since real options method permits the valuation of options that might arise during the R&D process and provides flexibility to managers to act, it results in higher values compared to discounted cash flow method. The grant from a public institution that partially financed the Project reduces the discount factor and thus increases the value of it. Conclusions: Economic values of biotechnology intangibles in developing countries are affected by country and sector risks and public financing. Thus, both microeconomic and macroeconomic policy interventions are important for the development of biotechnology in these economies. While public financing enables the risky R&D projects to take place, it makes them more valuable than they would be under no intervention. Long run effects of these interventions require diligent analyses.
author	Erbas,Bahar Celikkol Memis,Selin Arslanhan
author_facet	Erbas,Bahar Celikkol Memis,Selin Arslanhan
author_sort	Erbas,Bahar Celikkol
title	An economic valuation of a biotechnology R&D project in a developing economy
title_short	An economic valuation of a biotechnology R&D project in a developing economy
title_full	An economic valuation of a biotechnology R&D project in a developing economy
title_fullStr	An economic valuation of a biotechnology R&D project in a developing economy
title_full_unstemmed	An economic valuation of a biotechnology R&D project in a developing economy
title_sort	economic valuation of a biotechnology r&d project in a developing economy
publisher	Pontificia Universidad Católica de Valparaíso
publishDate	2012
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582012000300001
work_keys_str_mv	AT erbasbaharcelikkol aneconomicvaluationofabiotechnologyrdprojectinadevelopingeconomy AT memisselinarslanhan aneconomicvaluationofabiotechnologyrdprojectinadevelopingeconomy AT erbasbaharcelikkol economicvaluationofabiotechnologyrdprojectinadevelopingeconomy AT memisselinarslanhan economicvaluationofabiotechnologyrdprojectinadevelopingeconomy
_version_	1718441854436900864

An economic valuation of a biotechnology R&D project in a developing economy

Ejemplares similares